产品展示
5ug重组人成纤维细胞生长因子19,Human FGF-19
【简单介绍】
【详细说明】
Catalogue Number | CYT-700 | ||
Synonyms | Fibroblast growth factor 19, FGF-19, FGF19. | ||
Introduction | The FGFs are a family of more than 20 small (~17–26 kDa) secreted peptides. The initial characterization of these proteins focused on their ability to stimulate fibroblast proliferation. This mitogenic activity was mediated through FGF receptors (FGFRs) 1, 2, or 3. A fourth closely related tyrosine kinase receptor (FGFR4) was able to bind the FGFs but did not lead to a mitogenic response. FGFs modulate cellular activity via at least 5 distinct subfamilies of high-affinity FGF receptors (FGFRs): FGFR-1, -2, -3, and -4, all with intrinsic tyrosine kinase activity and, except for FGFR-4, multiple splice isoforms, and FGFR-5, which lacks an intracellular kinase domain. There is growing evidence that FGFRs can be important for regulation of glucose and lipid homeostasis. The overexpression of a dominant negative form of FGFR-1 in ? cells leads to diabetes in mice, which thus implies that proper FGF signaling is required for normal ? cell function and glycemia maintenance. FGFR-2 appears to be a key molecule during pancreatic development. Moreover, FGFR-4 has been implicated in cholesterol metabolism and bile acid synthesis. FGF-19, has been shown to cause resistance to diet-induced obesity and insulin desensitization and to improve insulin, glucose, and lipid profiles in diabetic rodents. Since these effects, at least in part, are mediated through the observed changes in metabolic rates, FGF-19 can be considered as a regulator of energy expenditure. FGF-21 is preferentially expressed in liver, but an exact knowledge of FGF-21 bioactivity and its mode of action have been lacking to date. FGF-21 is a potent activator of glucose uptake on adipocytes, protects animals from diet-induced obesity when overexpressed in transgenic mice, and lowers blood glucose and triglyceride levels when therapeutically administered to diabetic rodents. | ||
Description | FGF19 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 195 amino acids and having a molecular mass of 21.8 kDa. The FGF-19 is purified by proprietary chromatographic techniques. | ||
Source | Escherichia Coli. | ||
Physical Appearance | Filtered white lyophilized powder. | ||
Formulation | Filtered (0.4 µm) and lyophilized from 1mg/ml in 1x PBS, pH 7.4. | ||
Solubility | Add deionized water to a working concentration approximay 0.5 mg/ml and let the lyophilized pellet dissolve compley. | ||
Stability | Lyophilized FGF-19 Human Recombinant although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution Fibroblast Growth Factor-19 should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. | ||
Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of balb/c 3T3 cells is 100-150ng/ml. | ||
Purity | Greater than 95.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. | ||
Amino acid sequence | MRPLAFSDAG PHVHYGWGDP IRLRHLYTSG PHGLSSCFLR IRADGVVDCA RGQSAHSLLE IKAVALRTVA IKGVHSVRYL CMGADGKMQG LLQYSEEDCA FEEEIRPDGY NVYRSEKHRL PVSLSSAKQR QLYKNRGFLP LSHFLPMLPM VPEEPEDLRG HLESDMFSSP LETDSMDPFG LVTGLEAVRS PSFEK. | ||
Usage | ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs,agricultural or pesticidal products, food additives or household chemicals. | ||
Related Products |
|
相关产品
- 1mg人低密度脂蛋白(Human LDL)
- 500TCCK-8细胞增殖/存活试剂盒(CCK-8 kit)
- 5ug重组人生长分化因子5H,Human GDF5 H
- 2ug重组人生长分化因子5D,Human GDF5 D
- 2ug重组人生长分化因子15,Human GDF15
- 5ug重组人生长分化因子10,Human GDF10
- 5ug重组人生长分化因子5,Human GDF5 His
- 10ug重组人生长分化因子5,Human GDF5
- 5ug重组人生长分化因子3,Human GDF3
- 2ug重组人胶质细胞源性神经营养因子,Human GDNF
- 5ug重组人半乳糖凝集素相关蛋白,Human LGALSL
- 1ug重组人半乳糖凝集素14,Human LGALS14
- 20ug重组人半乳糖凝集素13,Human LGALS13
- 2ug重组人半乳糖凝集素9,Human LGALS9
- 2ug重组人半乳糖凝集素8,Human LGALS8 His
- 2ug重组人半乳糖凝集素8,Human LGALS8
- 5ug重组人半乳糖凝集素7,Human LGALS7 His
- 2ug重组人半乳糖凝集素7,Human LGALS7
- 5ug重组人半乳糖凝集素4,Human LGALS4
- 5ug重组人半乳糖凝集素3,Human LGALS3 His
- 10ug重组人半乳糖凝集素3,Human LGALS3
- 5ug重组人半乳糖凝集素2,Human LGALS2
- 10ug重组人半乳糖凝集素1,Human LGALS1
- 10ug重组小鼠肝素结合性表皮生长因子 ,Mouse HB-EGF
- 10ug重组人肝素结合性表皮生长因子 ,Human HB-EGF
- 2ug重组小鼠卵泡抑素,Mouse FST
- 2ug重组人卵泡抑素,Human FST His
- 5ug重组人卵泡抑素,Human FST
- 2ug重组小鼠FMS相关酪胺酸激酶3配体,Mouse Flt3 Ligand
- 2ug重组人FMS相关酪胺酸激酶3配体,Human Flt3 Ligand Sf9
- 2ug重组人FMS相关酪胺酸激酶3配体,Human Flt3 Ligand HEK
- 2ug重组人FMS相关酪胺酸激酶3配体,Human Flt3 Ligand
- 2ug重组人成纤维细胞生长因子23,Human FGF-23 C-term
- 2ug重组人成纤维细胞生长因子23,Human FGF-23 His
- 5ug重组人成纤维细胞生长因子23,Human FGF-23
- 2ug重组人成纤维细胞生长因子22,Human FGF-22
- 2ug重组牛成纤维细胞生长因子21,Bovine FGF-21
- 2ug重组小鼠成纤维细胞生长因子21,Mouse FGF-21 His
- 10ug重组绵羊催乳素受体拮抗剂,Ovine Prl-A Mutant
- 10ug重组绵羊催乳素受体拮抗剂,Ovine Prl-A